Pharmarise Holdings Corp.'s market cap is currently ¥6.16B. The company's EPS TTM is ¥-1.62; its P/E ratio is ―; and it has a dividend yield of 2.61%. Pharmarise Holdings Corp. is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in JPY
Pharmarise Holdings Corp. Earnings and Revenue History
